Ftse Mib
34.825,01
-1,62%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
71.308,59
-0,20%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Correvio Pharma Corporation (CORV) Correvio Pharma Corporation (CORV) Notizie

CORV

Correvio Pharma (CORV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CORV
DataOraFonteTitoloSimboloCompagnia
09/06/202012:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CORVCorrevio Pharma Corporation
28/05/202012:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CORVCorrevio Pharma Corporation
27/05/202022:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CORVCorrevio Pharma Corporation
27/05/202019:01Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CORVCorrevio Pharma Corporation
27/05/202012:06Edgar (US Regulatory)Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 193...NASDAQ:CORVCorrevio Pharma Corporation
27/05/202012:03Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CORVCorrevio Pharma Corporation
27/05/202012:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CORVCorrevio Pharma Corporation
26/05/202023:30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CORVCorrevio Pharma Corporation
21/05/202022:01PR Newswire (US)Correvio Obtains Final Order for Plan of ArrangementNASDAQ:CORVCorrevio Pharma Corporation
15/05/202023:55PR Newswire (Canada)Correvio Announces Results from Annual General and Special Meeting of SecurityholdersNASDAQ:CORVCorrevio Pharma Corporation
06/05/202014:00PR Newswire (US)Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVAN...NASDAQ:CORVCorrevio Pharma Corporation
04/05/202014:00PR Newswire (US)Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19NASDAQ:CORVCorrevio Pharma Corporation
01/05/202014:00PR Newswire (US)Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMANASDAQ:CORVCorrevio Pharma Corporation
30/04/202012:23Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CORVCorrevio Pharma Corporation
21/04/202003:56PR Newswire (US)SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?NASDAQ:CORVCorrevio Pharma Corporation
16/04/202023:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CORVCorrevio Pharma Corporation
08/04/202022:05PR Newswire (Canada)Correvio Obtains Interim Order For Plan Of ArrangementNASDAQ:CORVCorrevio Pharma Corporation
30/03/202013:00PR Newswire (Canada)Correvio Reports Full Year 2019 Financial ResultsNASDAQ:CORVCorrevio Pharma Corporation
16/03/202012:00PR Newswire (Canada)ADVANZ PHARMA to Acquire CorrevioNASDAQ:CORVCorrevio Pharma Corporation
10/03/202012:30PR Newswire (US)Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in ChinaNASDAQ:CORVCorrevio Pharma Corporation
02/03/202014:30PR Newswire (US)Correvio Responds to Market ActivityNASDAQ:CORVCorrevio Pharma Corporation
28/01/202014:00PR Newswire (US)Correvio Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed SecuritiesNASDAQ:CORVCorrevio Pharma Corporation
09/01/202007:05PR Newswire (US)LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the FirmNASDAQ:CORVCorrevio Pharma Corporation
24/12/201914:00PR Newswire (Canada)Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent EventsNASDAQ:CORVCorrevio Pharma Corporation
16/12/201923:36Business WireShareholder Alert: Robbins LLP Announces Correvio Pharma Corp. (CORV) Sued for Misleading ShareholdersNASDAQ:CORVCorrevio Pharma Corporation
11/12/201914:00PR Newswire (US)Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder ValueNASDAQ:CORVCorrevio Pharma Corporation
10/12/201922:38PR Newswire (US)Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess™ For The Treatment Of Recent Onset Atrial ...NASDAQ:CORVCorrevio Pharma Corporation
10/12/201913:05PR Newswire (US)Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess™ For Recent Onset Atrial Fibrillat...NASDAQ:CORVCorrevio Pharma Corporation
25/11/201914:00PR Newswire (Canada)Correvio to Present at the Piper Jaffray 31st Annual Healthcare ConferenceNASDAQ:CORVCorrevio Pharma Corporation
18/11/201914:00PR Newswire (Canada)Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual MeetingNASDAQ:CORVCorrevio Pharma Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CORV

La tua Cronologia

BIT
UC2HDW
UniCredit Bank
BIT
MWRD
Amundi Msci World Ucits ...
NASDAQ
HWEL
Healthwell Acquisition C...
ASX
WFA
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network